Huimin Du
Chongqing Key Laboratory Of Molecular Oncology And Epigenetics
Chongqing, China
Chongqing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Macrophage ALDH2 drives immunotherapy resistance by silencing CXCL9 through metabolic-epigenetic crosstalk.
Journal: Nature communications
Published: August 11, 2025
Optimal Sca-1-based procedure for purifying mouse adipose-derived mesenchymal stem cells with enhanced proliferative and differentiation potential.
Journal: Frontiers in cell and developmental biology
Published: January 25, 2025
Noncoding RNAs in sepsis-associated acute liver injury: Roles, mechanisms, and therapeutic applications.
Journal: Pharmacological research
Published: November 05, 2024
AEBP1 drives fibroblast-mediated T cell dysfunction in tumors.
Journal: Nature communications
Published: August 22, 2024
Insulin-like growth factor 2 drives fibroblast-mediated tumor immunoevasion and confers resistance to immunotherapy.
Journal: The Journal of clinical investigation
Published: May 29, 2024
Acetylation-dependent deubiquitinase USP26 stabilizes BAG3 to promote breast cancer progression.
Journal: Cancer letters
Published: March 13, 2024
Novel prognostic biomarker TBC1D1 is associated with immunotherapy resistance in gliomas.
Journal: Frontiers in immunology
Published: January 17, 2024
Aldehyde dehydrogenase 2-mediated aldehyde metabolism promotes tumor immune evasion by regulating the NOD/VISTA axis.
Journal: Journal for immunotherapy of cancer
Published: November 21, 2023
Plasticity and crosstalk of mesenchymal stem cells and macrophages in immunomodulation in sepsis.
Journal: Frontiers in immunology
Published: November 15, 2023
Last Updated: 09/26/2026